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The present study investigated the effect of serum concentration of androgens, LH and IGF1 in the
early follicular phase on the results of the ovulation induction (I/O) and intrauterine insemination
(IUI) cycles.Materials andmethods: This prospective observational cross-sectional study was carried
out in the infertility department of a university hospital in Tehran, Iran. The case’s selection was
based on the inclusion and exclusion criteria and was nonrandomized. 59 patients under the age of
45 who were candidate for induction ovulation (I/O) or intrauterine insemination were included.
The inclusion criteria consist of infertility for at least one year and at least one open tube in HSG.
Patients were excluded if they had polycystic ovary syndrome (PCOS) or endometriosis. The serum
concentration of androgens (testosterone, dehydroepiandrosterone and androstenedione), LH and
IGF1 was measured on the third day of menstruation. Clomiphene and human menopausal gonado-
tropin (HMG) were drugs of induction ovulation. Human chorionic gonadotropin (HCG) was
injected when there was at least one follicle with the size of (18 mm). IUI was done 36 h later for eli-
gible patients and the relation of concentration of androgens, LH and IGF1 with follicular growth
parameters and pregnancy rate was analyzed. Results: There was not any statistical significant link
between the number and size of follicles with levels of free testosterone, dehydroepiandrosterone,
androstenedione, IGF1 and LH. There was not any statistical significant link between the number
58 Z. Raoofi et al.of follicles in the ovaries and levels of testosterone (P= 0.090 and r= 0.223), dehydroepiandros-
terone (P= 0.642 and r= 0.062) and androstenedione (P= 0.526 and r= 0.084), IGF1
(P= 0.470 and r= 0.096) and LH (P= 0.446 and r= 0.102). There was not any statistical signif-
icant link between the mean follicular size with levels of testosterone (P= 0.822 and r= 0.03), dehy-
droepiandrosterone (P= 0.733 and r= 0.045) and androstenedione (P= 0.526 and r= 0.084),
IGF1 (P= 0.799 and r= 0.034) and LH (P= 0.626 and r= 0.065). Beta Human chorionic gona-
dotropin (beta-hCG) was positive in 11 patients (18.6%) and negative in 48 patients (81.4%). Serum
level of androgen profile, LH and IGF1 in positive BHCG group was lower than negative BHCG
group but was not significantly different. Conclusion: It seems that in women who were not affected
by PCO, concentration of free testosterone, dehydroepiandrosterone, androstenedione, IGF1 and
LH in early follicular phase was not related to follicular growth parameters and pregnancy rate.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Middle East Fertility Society.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
The androgens as the precursors of estrogens in ovary have the
important role in follicular maturation and ovulation. This
effect may result in assuming them as the future generation
of drugs for induction ovulation. But the exact knowledge of
the androgen effects on human follicle maturation does not
exist and yet has remained controversial (1,2).
QIN and his colleagues evaluated the baseline level of
testosterone during the follicular phase as a predictor of ovar-
ian response and IVF results, and 1260 Chinese women with-
out endometriosis or polycystic ovarian syndrome who
underwent IVF cycle, were evaluated. These patients were
divided into two groups with limited ovarian reserve (base
FSH levels over IU/L 10) (187 patients) and normal ovarian
reserve (base FSH levels less than or equal IU/L 10) (1073 peo-
ple). The results of this study showed that baseline testosterone
level in women with limited ovarian reserve is a predictor of
large follicles and pregnancy (3).
In a study that was conducted in 2011 by Gleicher and col-
leagues, he examined the role of androgens in follicular matura-
tion and ovulation in infertile patients. According to the results
of this study that reviewed 217 published articles between 2005
and 2011, androgen had an important role in follicular matura-
tion and fertility of women (1). A study conducted by Meldrum
and his colleagues examined the role of decreased androgens in
the ovarian response to stimulation in older women. Based on
these results, increased serum levels of IGF-1, exogenous and
local testosterone in the ovaries were associated with increased
ovarian response to gonadotropins (4).
Gleicher also investigated the conversion rate of dehy-
droepiandrosterone in diminished ovarian reserve patients
and concluded that women who conceived had a better con-
vention rate (2). Also because insulin growth factor-1 (IGF-
1) is essential for the conversion of androgens to estrogens this
study aimed to evaluate the basal concentration of different
types of androgens, LH and (IGF-1) in the early follicular
phase of the cycle on ovulation induction (I/O) and intrauter-
ine insemination (IUI) results.
2. Material and methods
This prospective observational cross-sectional study was car-
ried out in the infertility department of a university hospitalin Tehran, Iran. This study was approved by ethics committee
of Iran University of Medical Sciences. The case’s selection
was based on the inclusion and exclusion criteria and was
nonrandomized. All cases provided written informed consent
before study registration. 59 patients under the age of 45
who were candidate for induction ovulation (I/O) or intrauter-
ine insemination were included. The inclusion criteria consist
of infertility for at least one year and at least one open tube
in HSG. Patients were excluded if they had PCOS or
endometriosis. Blood samples were collected on the third day
of menstruation and the serum level of androgens (testos-
terone, dehydroepiandrosterone and androstenedione), LH
and IGF1 was measured. Also, all the patients underwent
transvaginal ultrasound to record and collect the base data.
Clomiphene and human menopausal gonadotropin (HMG)
were drugs of induction ovulation. Sonographic monitoring
was started from the ninth day of the cycle. HCG was injected
when there was at least one follicle with the size of (18 mm).
IUI was done 36 h later for eligible patients and the records
were collected by completing a checklist. The relation of con-
centration of androgens, LH and IGF1 with follicular growth
parameters and pregnancy rate was analyzed by using SPSS
software. Chi-2 test and Independent sample t-test were used
to examine the relation between variables.3. Results
59 patients entered the study that had a mean age of 32.1
± 5.3 years, with the minimum and maximum ages of 20
and 44 years old. The mean and standard deviation of height,
weight and body mass index of patients who entered the study
were 158.3 ± 13.3, 66.6 ± 16.5 and 25.4 ± 4.9 respectively.
The mean and standard deviation of the infertility periods
were 49.1 ± 36.3 months that the lowest and highest were 12
and 156 months, respectively. BHCG was positive in 11
patients (18.6%) and negative in 48 patients (81.4%). Table 1
shows the relationship between level of androgen profiles, LH
and IGF1 and BHCG results.
There was not any statistically significant link between the
number of follicles in the ovaries and levels of testosterone
(P= 0.090 and r= 0.223), dehydroepiandrosterone
(P= 0.642 and r= 0.062) and androstenedione (P= 0.526
and r= 0.084), IGF1 (P= 0.470 and r= 0.096) and LH
(P= 0.446 and r= 0.102). There was not any statistically
Table 1 Level of androgen profiles, LH and IGF1 and BHCG
results.
Positive
BHCG
Negative
BHCG
P
Testosterone
(nanomole/liter)
0.95 ± 0.93 0.95 ± 1.1 0.170
DHEA (nanomole/liter) 0.31 ± 1.1 0.6 ± 1.3 0.280
Androstenedione
(nanomole/liter)
0.42 ± 1 0.5 ± 1.1 0.575
LH (IU/L) 2.2 ± 1.5 2.8 ± 2.6 0.178
IGF1 (nanogr/milliliter) 21.8 ± 113.4 34.7 ± 125.4 0.632
Mean follicular size 2.9 ± 15.15 2.1 ± 14.36 0.168
Table 2 Comparison of androgen levels, LH and IGF1 by age
group.
Younger than
35 years
Older than
35 years
P
Testosterone
(nanomole/liter)
0.99 ± 1.09 0.93 ± 1.03 0.859
DHEA (nanomole/liter) 0.56 ± 1.2 0.79 ± 1.4 0.708
Androstenedione
(nanomole/liter)
0.53 ± 1.1 0.37 ± 1.1 0.331
LH (IU/L) 2.9 ± 2.3 2.4 ± 2.8 0.261
IGF1 (nanogr/milliliter) 30.2 ± 122.2 39.5 ± 125.4 0.382
Table 3 LH/IGF1, testosterone/IGF1, ASD/IGF1 and
DHEA/IGF1 ratios in positive and negative BHCG groups.
Negative BHCG Positive BHCG P
LH/IGF1 0.025 ± 0.021 0.022 ± 0.014 0.173
Testosterone/IGF1 0.005 ± 0.008 0.004 ± 0.007 0.572
ASD/IGF1 0.002 ± 0.009 0.001 ± 0.009 0.930
LH/IGF1 0.005 ± 0.010 0.001 ± 0.009 0.508
Androgens were not related to follicular growth 59significant link between the mean follicular size with levels of
testosterone (P= 0.822 and r= 0.03), dehydroepiandros-
terone (P= 0.733 and r= 0.045) and androstenedione
(P= 0.526 and r= 0.084), IGF1 (P= 0.799 and r= 0.034)
and LH (P= 0.626 and r= 0.065).
The patients were divided into two groups based on their
age, younger than 35 years and older than 35 years, and the
androgen levels, LH and IGF1 were compared between the
two groups which is shown in Table 2.
The number of follicles also was not significantly different
between two age groups (4.12 ± 4 v/s 2.8 ± 3.7 P= 0.341).
In patients younger than 35 years, Serum level of Testos-
terone (P= 0.374), dehydroepiandrosterone (P= 0.353),
androstenedione (P= 0.652), IGF1 (P= 0.805) and LH
(P= 0.611) in positive BHCG group was lower than negative
BHCG group but not significantly different. In patients older
than 35 years, Serum level of Testosterone (P= 0.235), dehy-
droepiandrosterone (P= 0.706), androstenedione
(P= 0.941), IGF1 (P= 0.784) and LH (P= 0.118) in posi-
tive BHCG group was lower than in negative BHCG group
but not significantly different. Table 3 compares LH/IGF1,Testosterone/IGF1, ASD/IGF1 and DHEA/IGF1 ratios by
the results of BHCG.
4. Discussion
The role of androgens in follicular development and ovulation
is controversial. The present study cannot show any positive or
negative relationship between the concentration of selective
androgens (free testosterone, dehydroepiandrosterone,
androstenedione), LH, IGF-1 and androgens/IGF-1 in the
early follicular phase and the follicular growth parameters
and the pregnancy rate.
Environmental endocrine system plays the main role in
oocyte maturation and ovulation. The oocytes with lower
quality were seen in women with PCO faced with hyperandro-
genism. Okon showed that increase in plasma androgens
causes recurrent abortion (5). Horie also reported that andro-
gens with detrimental effects on endometrial development can
cause raise of miscarriage (6).
In the past few years, it was assumed that androgens have a
positive role in follicle development. Androgens affect follicle
maturation from very early stages and stimulate the transition
from primary to secondary follicle (7). Weil suggested a pri-
mary importance for androgens, especially in the early stages
of follicle maturation (8).
Gerva´sio review indicates that during the early and inter-
mediate stages of follicular maturation, the androgens locally
produced by the developing follicles, control the follicle transi-
tion from the reserve pool to the growth pool and also control
the promotion of subsequent follicle development. The fall in
AR expression in mature follicles reduces the action of andro-
gens which is a key event during the processes of follicular
selection and atresia (9). Androgens may affect folliculogenesis
directly via androgen receptors (ARs) or indirectly through
aromatization to estrogen. ARs are highly expressed in the
granulosa and theca cells of early stage follicles and are slightly
expressed in mature follicles. Short-term androgen exposure
augments the FSH receptor expression in the granulosa cells
of developing follicles and controls the follicular cell prolifera-
tion and differentiation. AR activation also increases insulin-
like growth factor (IGF-1) in the granulosa and theca cells
of growing follicles, and in the oocytes of primordial follicles
and facilitates the IGF-1 actions in both follicular recruitment
and subsequent development (9).
But about the role of androgens in subsequent follicular
development, Gleicher review showed the effects of androgens
in improving human ovulation induction and demonstrated
the essential contribution of androgens to normal follicle mat-
uration. He suggested that some androgens, such as testos-
terone (T) and dehydroepiandrosterone (DHEA), are
effective in improving functional ovarian reserve (FOR) in
women with diminished ovarian reserve (DOR), but others
may have opposite effects (1).
Sun evaluated basal testosterone (T) levels in women
undergoing in vitro fertilization (IVF) cycles. He showed
basal T level positively correlated with ovarian reserve func-
tion, number of mature follicles and total gonadotropin
dose but couldn’t predict IVF pregnancy outcome. He con-
cluded that basal T level can be used as a good predictor
for ovarian response and also as a marker to predict FSH
dosage (10).
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women with DOR improves IVF cycle outcomes and preg-
nancy chances which shows the androgen effects on human
follicle maturation. But, how DHEA causes these effects has
remained undetermined.
Gleicher studied the androgen conversion rate after supple-
mentation with dehydroepiandrosterone in patients with
diminished ovarian reserve who were candidate for in vitro fer-
tilization. He concluded that women who conceived had a bet-
ter conversion rate (2).
IGF-1 stimulates the DNA synthesis, steroidogenesis, and
aromatase activity (11). It has a critical role in the conversion
of androgens and the building of a suitable environment for
the ovum. Our result does not show any difference in IGF-1
and also androgens/IGF-1 in the conceived group.
Androgens/IGF-1 was evaluated because it can be a factor in
aromatization and optimal androgen environment. However
we couldn’t evaluate the local bioactivity of the androgens
which was the limitation of our study. It is suggested that fur-
ther study must focus on factors that affect conversion and
bioactivity of androgens.
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